Danaher (NYSE:DHR) CAO Christopher Bouda Sells 7,598 Shares of Stock

Key Points

• Danaher CAO Christopher Bouda sold 7,598 shares at an average price of $234.56, generating approximately $1.78 million. He retained 9,107 shares, a 45.48% reduction in his holdings.
• Danaher reported quarterly EPS of $2.11, exceeding the $1.92 consensus estimate, while revenue rose 8.3% year over year to $6.55 billion.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $242.91; the company also declared a quarterly dividend of $0.40 per share.

Danaher Corporation (NYSE:DHR - Get Free Report) CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares of the company's stock, valued at approximately $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Danaher Price Performance

Shares of NYSE DHR traded up $2.70 during mid-day trading on Thursday, reaching $236.77. The company had a trading volume of 2,700,021 shares, compared to its average volume of 4,479,928. The firm has a market cap of $166.58 billion, a price-to-earnings ratio of 38.75, a PEG ratio of 2.89 and a beta of 0.76. The business's 50-day simple moving average is $218.10 and its 200 day simple moving average is $201.81. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The company had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. During the same quarter last year, the company posted $1.89 EPS. The company's revenue for the quarter was up 8.3% compared to the same quarter last year. On average, research analysts predict that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher's payout ratio is 26.19%.

Institutional Investors Weigh In On Danaher

Institutional investors and hedge funds have recently modified their holdings of the stock. Trek Financial LLC lifted its stake in shares of Danaher by 23.9% in the 3rd quarter. Trek Financial LLC now owns 12,701 shares of the conglomerate's stock valued at $2,814,000 after acquiring an additional 2,450 shares during the last quarter. Columbia Bank bought a new position in Danaher during the 3rd quarter worth approximately $233,000. Hoey Investments Inc. increased its stake in Danaher by 2,590.0% in the 3rd quarter. Hoey Investments Inc. now owns 538 shares of the conglomerate's stock worth $119,000 after purchasing an additional 518 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Danaher by 3.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,861,336 shares of the conglomerate's stock valued at $412,379,000 after purchasing an additional 68,792 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Danaher in the third quarter worth approximately $47,560,000. Institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on DHR shares. TD Cowen raised their price objective on Danaher from $255.00 to $270.00 and gave the company a "buy" rating in a research note on Thursday, October 22nd. Barclays lifted their target price on Danaher from $255.00 to $260.00 and gave the company an "overweight" rating in a report on Thursday, October 22nd. Stifel Nicolaus increased their price target on shares of Danaher from $220.00 to $260.00 and gave the stock a "buy" rating in a report on Thursday, October 22nd. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Monday. Finally, Robert W. Baird boosted their price target on shares of Danaher from $246.00 to $254.00 and gave the company an "outperform" rating in a research report on Thursday, October 22nd. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $242.91.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.